SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 9/21/22 Aurora Cannabis Inc. 40-F 6/30/22 169:45M |
Document/Exhibit Description Pages Size 1: 40-F Annual Report by a Canadian Issuer HTML 767K 2: EX-99.1 Miscellaneous Exhibit HTML 46K 3: EX-99.2 Miscellaneous Exhibit HTML 46K 4: EX-99.3 Miscellaneous Exhibit HTML 43K 5: EX-99.4 Miscellaneous Exhibit HTML 43K 6: EX-99.5 Miscellaneous Exhibit HTML 3.32M 7: EX-99.6 Miscellaneous Exhibit HTML 919K 8: EX-99.7 Miscellaneous Exhibit HTML 283K 9: EX-99.8 Miscellaneous Exhibit HTML 43K 15: R1 Cover HTML 100K 16: R2 Audit Information HTML 47K 17: R3 Consolidated Statements of Financial Position HTML 148K 18: R4 Consolidated Statements of Comprehensive Loss HTML 199K 19: R5 Consolidated Statements of Changes in Equity HTML 118K 20: R6 Consolidated Statements of Changes in Equity HTML 48K (Parenthetical) 21: R7 Consolidated Statements of Cash Flows HTML 140K 22: R8 Nature of Operations HTML 48K 23: R9 Significant Accounting Policies and Judgments HTML 71K 24: R10 Restructuring Provision HTML 69K 25: R11 Accounts Receivable HTML 55K 26: R12 Government Grant HTML 47K 27: R13 Investments HTML 70K 28: R14 Marketable Securities and Derivatives HTML 146K 29: R15 Investments in Associates and Joint Ventures HTML 74K 30: R16 Biological Assets HTML 55K 31: R17 Inventory HTML 77K 32: R18 Property, Plant and Equipment HTML 137K 33: R19 Assets and Liabilities Held for Sale and HTML 118K Discontinued Operations 34: R20 Business Combinations HTML 68K 35: R21 Asset Acquisition and Non-controlling Interest HTML 51K (?Nci?) 36: R22 Intangible Assets and Goodwill HTML 172K 37: R23 Convertible Debentures HTML 66K 38: R24 Share Capital HTML 99K 39: R25 Share-Based Compensation HTML 124K 40: R26 Loss Per Share HTML 54K 41: R27 Other Gains (Losses) HTML 60K 42: R28 Supplemental Cash Flow Information HTML 61K 43: R29 Income Taxes HTML 153K 44: R30 Related Party Transactions HTML 69K 45: R31 Commitments and Contingencies HTML 69K 46: R32 Revenue HTML 66K 47: R33 Segmented Information HTML 80K 48: R34 Fair Value of Financial Instruments HTML 116K 49: R35 Financial Instruments Risk HTML 88K 50: R36 Capital Management HTML 46K 51: R37 Subsequent Events HTML 46K 52: R38 Lease Liabilities HTML 62K 53: R39 Significant Accounting Policies and Judgments HTML 273K (Policies) 54: R40 Significant Accounting Policies and Judgments HTML 52K (Tables) 55: R41 Restructuring Provision (Tables) HTML 49K 56: R42 Accounts Receivable (Tables) HTML 52K 57: R43 Marketable Securities and Derivatives (Tables) HTML 145K 58: R44 Investments in Associates and Joint Ventures HTML 98K (Tables) 59: R45 Biological Assets (Tables) HTML 97K 60: R46 Inventory (Tables) HTML 73K 61: R47 Property, Plant and Equipment (Tables) HTML 117K 62: R48 Assets and Liabilities Held for Sale and HTML 102K Discontinued Operations (Tables) 63: R49 Business Combinations (Tables) HTML 59K 64: R50 Asset Acquisition and Non-controlling Interest HTML 47K (?Nci?) (Tables) 65: R51 Intangible Assets and Goodwill (Tables) HTML 171K 66: R52 Convertible Debentures (Tables) HTML 57K 67: R53 Share Capital (Tables) HTML 91K 68: R54 Share-Based Compensation (Tables) HTML 118K 69: R55 (Loss) Earnings Per Share (Tables) HTML 52K 70: R56 Other Gains (Losses) (Tables) HTML 60K 71: R57 Supplemental Cash Flow Information (Tables) HTML 62K 72: R58 Income Taxes (Tables) HTML 150K 73: R59 Related Party Transactions (Tables) HTML 67K 74: R60 Commitments and Contingencies (Tables) HTML 47K 75: R61 Revenue (Tables) HTML 58K 76: R62 Segmented Information (Tables) HTML 77K 77: R63 Fair Value of Financial Instruments (Tables) HTML 158K 78: R64 Financial Instruments Risk (Tables) HTML 81K 79: R65 Lease Liabilities (Tables) HTML 57K 80: R66 Significant Accounting Policies and Judgments - HTML 63K Major Subsidiaries Over Which the Company Has Control (Details) 81: R67 Restructuring Provision - Narrative (Details) HTML 51K 82: R68 Restructuring Provision - Rollforward of HTML 49K Restructuring Provision (Details) 83: R69 Accounts Receivable (Details) HTML 56K 84: R70 Government Grant (Details) HTML 56K 85: R71 Investments - Choom Holdings Inc. (Details) HTML 123K 86: R72 Investments - Australis Capital Inc. (Details) HTML 71K 87: R73 Investments - Radient Technologies Inc. (Details) HTML 54K 88: R74 Investments - Cann Group Limited (Details) HTML 75K 89: R75 Investments - Capcium, Inc. (Details) HTML 81K 90: R76 Investments - Investee - B (Details) HTML 92K 91: R77 Investments - High Tide Inc. (Details) HTML 155K 92: R78 Investments - Investee C (Details) HTML 64K 93: R79 Marketable Securities and Derivatives - Marketable HTML 103K Securities (Details) 94: R80 Marketable Securities and Derivatives - Derivative HTML 107K Investments (Details) 95: R81 Investments in Associates and Joint Ventures - HTML 77K Summary of Carrying Value (Details) 96: R82 Biological Assets - Significant Unobservable HTML 61K Assumptions Used in the Valuation of Biological Assets, Including Sensitivities (Details) 97: R83 Biological Assets - Changes in Carrying Value of HTML 58K Biological Assets (Details) 98: R84 Biological Assets - Narrative (Details) HTML 56K 99: R85 Inventory (Details) HTML 89K 100: R86 Property, Plant and Equipment - Narrative HTML 100K (Details) 101: R87 Property, Plant and Equipment - Carrying Values of HTML 171K Property, Plant and Equipment (Details) 102: R88 Assets and Liabilities Held for Sale and HTML 108K Discontinued Operations - Assets Held For Sale (Details) 103: R89 Assets and Liabilities Held for Sale and HTML 142K Discontinued Operations - Narrative (Details) 104: R90 Assets and Liabilities Held for Sale and HTML 68K Discontinued Operations - Discontinued Operations (Details) 105: R91 Business Combinations - Narrative (Details) HTML 71K 106: R92 Business Combinations - Business Combinations HTML 99K Completed (Details) 107: R93 Asset Acquisition and Non-controlling Interest HTML 57K (?NCI?) - Net Change in Non-Controlling Interests (Details) 108: R94 Asset Acquisition and Non-controlling Interest HTML 66K (?NCI?) - Narrative (Details) 109: R95 Intangible Assets and Goodwill - Useful Lives HTML 54K (Details) 110: R96 Intangible Assets and Goodwill - Continuity HTML 104K Schedule of Intangible Assets and Goodwill (Details) 111: R97 Intangible Assets and Goodwill - Changes in Net HTML 104K Book Value of Intangible Assets and Goodwill (Details) 112: R98 Intangible Assets and Goodwill - Narrative HTML 104K (Details) 113: R99 Intangible Assets and Goodwill - Key Assumptions HTML 95K Used in Impairment Testing (Details) 114: R100 Convertible Debentures - Activity of Convertible HTML 62K Debentures (Details) 115: R101 Convertible Debentures - Narrative (Details) HTML 124K 116: R102 Share Capital - Narrative (Details) HTML 140K 117: R103 Share capital - Summary of Shares Issued for HTML 53K Equity Financing (Details) 118: R104 Share Capital - Share Purchase Warrants (Details) HTML 44K 119: R105 Share Capital - Summary of Warrant Derivative HTML 57K Liabilities (Details) 120: R106 Share Capital - Summary of Warrants Outstanding HTML 64K (Details) 121: R107 Share-Based Compensation - Narrative (Details) HTML 80K 122: R108 Share-Based Compensation - Summary of Options HTML 71K Outstanding (Details) 123: R109 Share-Based Compensation - Stock Options that HTML 78K Remain Outstanding, by Exercise Price Range (Details) 124: R110 Share-Based Compensation - Weighted Average HTML 53K Assumptions of Options (Details) 125: R111 Share-Based Compensation - Summary of RSUs and HTML 76K DSUs Outstanding (Details) 126: R112 Share-Based Compensation - RSUs and DSUs that HTML 65K Remain Outstanding (Details) 127: R113 Share-Based Compensation - Summary of PSUs HTML 66K Outstanding (Details) 128: R114 Share-Based Compensation - PSUs that Remain HTML 65K Outstanding (Details) 129: R115 Share-Based Compensation - Weighted Average HTML 56K Assumptions of PSUs (Details) 130: R116 (Loss) Earnings Per Share (Details) HTML 76K 131: R117 Other Gains (Losses) (Details) HTML 70K 132: R118 Supplemental Cash Flow Information - Changes in HTML 62K Non-Cash Working Capital (Details) 133: R119 Supplemental Cash Flow Information - Supplementary HTML 54K Cash Flow Information (Details) 134: R120 Supplemental Cash Flow Information - Narrative HTML 49K (Details) 135: R121 Income Taxes - Narrative (Details) HTML 49K 136: R122 Income Taxes - Reconciliation of Net Tax Provision HTML 71K to Income (Loss) Before Income Tax (Details) 137: R123 Income Taxes - Movements in Deferred Tax Assets HTML 130K (Liabilities) (Details) 138: R124 Income Taxes - Deferred Tax Assets (Liabilities) HTML 50K (Details) 139: R125 Income Taxes - Deferred Tax Assets Not Recognized HTML 72K (Details) 140: R126 Related Party Transactions - Compensation Expense HTML 54K (Details) 141: R127 Related Party Transactions - Transactions with HTML 44K Related Parties (Details) 142: R128 Related Party Transactions - Receivable from HTML 74K (Payable to) Related Parties (Details) 143: R129 Commitments and Contingencies - Narrative HTML 66K (Details) 144: R130 Commitments and Contingencies - Future Commitments HTML 50K Including Minimum Royalty Payments Due in the Next Five Years (Details) 145: R131 Revenue - Narrative (Details) HTML 46K 146: R132 Revenue - Revenue from the Transfer of Goods and HTML 64K Services (Details) 147: R133 Segmented Information - Operating Segments HTML 64K (Details) 148: R134 Segmented Information - Geographical Segments HTML 57K (Details) 149: R135 Segmented Information - Narrative (Details) HTML 53K 150: R136 Fair Value of Financial Instruments - Carrying HTML 144K Values of Financial Instruments (Details) 151: R137 Fair Value of Financial Instruments - Summary of HTML 79K Financial Instruments Measured at Fair Value (Details) 152: R138 Fair Value of Financial Instruments - Continuity HTML 70K Schedule of Contingent Consideration Payable (Details) 153: R139 Fair Value of Financial Instruments - Narrative HTML 57K (Details) 154: R140 Financial Instruments Risk - Credit Risk Narrative HTML 50K (Details) 155: R141 Financial Instruments Risk - Schedule of Aging of HTML 51K Receivables (Details) 156: R142 Financial Instruments Risk - Schedule of HTML 67K Contractual Cash Flows from Lease Receivables (Details) 157: R143 Financial Instruments Risk - Schedule of Accounts HTML 57K Payable and Accrued Liabilities (Details) 158: R144 Financial Instruments Risk - Liquidity Risk HTML 51K Narrative (Details) 159: R145 Financial Instruments Risk - Market Risk Narrative HTML 64K (Details) 160: R146 Capital Management (Details) HTML 44K 161: R147 Subsequent Events (Details) HTML 47K 162: R148 Lease Liabilities - Lease Liabilities (Details) HTML 59K 163: R149 Lease Liabilities - Narrative (Details) HTML 44K 164: R9999 Uncategorized Items - _IXDS HTML 96K 167: XML IDEA XML File -- Filing Summary XML 318K 165: XML XBRL Instance -- acb-20220630_htm XML 6.98M 166: EXCEL IDEA Workbook of Financial Reports XLSX 407K 11: EX-101.CAL XBRL Calculations -- acb-20220630_cal XML 361K 12: EX-101.DEF XBRL Definitions -- acb-20220630_def XML 1.94M 13: EX-101.LAB XBRL Labels -- acb-20220630_lab XML 3.95M 14: EX-101.PRE XBRL Presentations -- acb-20220630_pre XML 2.64M 10: EX-101.SCH XBRL Schema -- acb-20220630 XSD 576K 168: JSON XBRL Instance as JSON Data -- MetaLinks 732± 1.14M 169: ZIP XBRL Zipped Folder -- 0001683541-22-000002-xbrl Zip 1.26M
a2022annualinformationfo |
This ‘40-F’ Filing | Date | Other Filings | ||
---|---|---|---|---|
11/30/25 | ||||
7/31/25 | ||||
6/1/25 | ||||
5/29/25 | ||||
3/31/25 | ||||
10/21/24 | ||||
9/9/24 | ||||
8/31/24 | ||||
8/22/24 | ||||
8/21/24 | ||||
7/23/24 | ||||
6/9/24 | ||||
6/1/24 | ||||
4/1/24 | ||||
3/31/24 | ||||
3/30/24 | ||||
3/16/24 | ||||
3/12/24 | ||||
3/8/24 | ||||
2/28/24 | ||||
1/26/24 | ||||
8/9/23 | ||||
12/31/22 | ||||
Filed as of: | 9/21/22 | |||
Filed on: | 9/20/22 | 6-K | ||
9/19/22 | ||||
8/31/22 | ||||
8/25/22 | 6-K | |||
For Period end: | 6/30/22 | |||
6/29/22 | ||||
6/1/22 | 6-K, SC 13G, SUPPL | |||
5/31/22 | 6-K, SUPPL | |||
5/30/22 | ||||
5/27/22 | 6-K, FWP, SUPPL | |||
5/18/22 | 6-K | |||
5/17/22 | ||||
5/13/22 | 6-K | |||
5/5/22 | 6-K | |||
3/31/22 | 6-K | |||
3/25/22 | ||||
3/24/22 | ||||
3/21/22 | ||||
2/28/22 | ||||
1/21/22 | ||||
1/4/22 | 6-K | |||
12/31/21 | 6-K | |||
12/15/21 | ||||
12/14/21 | 6-K | |||
12/6/21 | ||||
12/3/21 | ||||
11/30/21 | ||||
11/16/21 | 6-K | |||
11/12/21 | 6-K | |||
11/8/21 | 6-K | |||
11/2/21 | ||||
10/31/21 | ||||
9/30/21 | 6-K | |||
9/21/21 | ||||
9/7/21 | 6-K | |||
8/31/21 | ||||
8/25/21 | 6-K | |||
7/31/21 | ||||
7/26/21 | 6-K | |||
7/15/21 | 6-K | |||
7/7/21 | ||||
6/30/21 | 40-F | |||
6/9/21 | ||||
6/1/21 | 6-K, SC 13G/A | |||
5/27/21 | 6-K | |||
5/25/21 | 6-K | |||
5/24/21 | 25, 6-K, 8-A12B, CERT | |||
5/20/21 | 6-K, SUPPL | |||
5/13/21 | 6-K | |||
4/30/21 | 6-K | |||
3/31/21 | 6-K | |||
3/30/21 | F-10/A | |||
3/24/21 | ||||
1/27/21 | 6-K | |||
1/26/21 | 6-K, SUPPL | |||
1/21/21 | 6-K, FWP, SUPPL | |||
1/14/21 | ||||
1/4/21 | ||||
12/18/20 | ||||
12/16/20 | 6-K | |||
11/25/20 | 6-K | |||
11/20/20 | ||||
11/16/20 | 6-K, SUPPL | |||
11/13/20 | 6-K, 6-K/A, SUPPL | |||
10/28/20 | 6-K, F-10/A | |||
10/17/20 | ||||
10/2/20 | ||||
9/25/20 | 40-F | |||
9/22/20 | 6-K | |||
9/11/20 | 6-K | |||
9/8/20 | 6-K | |||
9/4/20 | ||||
8/31/20 | ||||
8/10/20 | ||||
7/6/20 | 6-K | |||
7/1/20 | ||||
6/30/20 | 40-F, 6-K | |||
6/26/20 | ||||
6/23/20 | 6-K | |||
6/18/20 | 6-K | |||
6/15/20 | ||||
6/9/20 | ||||
5/28/20 | 6-K, SUPPL | |||
5/27/20 | ||||
5/20/20 | 6-K | |||
5/11/20 | ||||
4/13/20 | 6-K | |||
3/25/20 | ||||
3/11/20 | ||||
2/13/20 | 6-K | |||
2/6/20 | 6-K | |||
2/3/20 | 6-K | |||
1/6/20 | ||||
12/31/19 | 6-K | |||
12/21/19 | 6-K | |||
12/20/19 | ||||
11/25/19 | ||||
11/21/19 | ||||
11/20/19 | 6-K | |||
11/18/19 | ||||
11/14/19 | 6-K | |||
10/17/19 | 6-K | |||
9/30/19 | 6-K | |||
9/18/19 | 6-K | |||
9/11/19 | 40-F, 6-K | |||
9/9/19 | 6-K | |||
8/15/19 | 6-K | |||
7/18/19 | 6-K | |||
7/15/19 | 6-K | |||
6/30/19 | 40-F, 40-F/A | |||
5/30/19 | ||||
3/31/19 | 6-K | |||
3/1/19 | ||||
12/31/18 | 6-K | |||
12/20/18 | ||||
11/1/18 | 6-K | |||
10/23/18 | ||||
10/17/18 | CERT | |||
5/28/18 | ||||
2/12/18 | ||||
12/31/17 | ||||
7/24/17 | ||||
5/30/17 | ||||
4/14/16 | ||||
2/4/16 | ||||
3/13/15 | ||||
10/2/14 | ||||
8/20/13 | ||||
12/21/06 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/28/23 Aurora Cannabis Inc. SUPPL 4/28/23 1:921K Donnelley … Solutions/FA 4/28/23 Aurora Cannabis Inc. SUPPL 4/28/23 1:832K Donnelley … Solutions/FA 4/28/23 Aurora Cannabis Inc. SUPPL 4/28/23 1:837K Donnelley … Solutions/FA 4/27/23 Aurora Cannabis Inc. F-10 5:627K Donnelley … Solutions/FA 11/25/22 Aurora Cannabis Inc. SUPPL 11/25/22 1:767K Donnelley … Solutions/FA 11/25/22 Aurora Cannabis Inc. SUPPL 11/25/22 1:771K Donnelley … Solutions/FA |